comparemela.com
Home
Live Updates
GSK posts blowout RSV vaccine sales, raises outlook : comparemela.com
GSK posts blowout RSV vaccine sales, raises outlook
The RSV shot, called Arexvy, booked £1.2 billion, or $1.5 billion, in sales after only being on the market for roughly half a year.
Related Keywords
Japan ,
Canada ,
United Kingdom ,
British ,
Emma Walmsley ,
Albert Bourla ,
Drug Administration ,
Pfizer ,
Chief Executive Officer Emma Walmsley ,
Business ,
Biotechnology ,
Biotech And Pharmaceuticals ,
Pharmaceuticals ,
Health Care Industry ,
Pfizer Inc ,
Gsk Plc ,
Moderna Inc ,
Earnings ,
Business News ,
comparemela.com © 2020. All Rights Reserved.